1.14.14.73	albendazole monooxygenase (sulfoxide-forming) deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24058654&form=6&db=m	Inducible CYP2J2 and Its Product 11,12-EET Promotes Bacterial Phagocytosis: A Role for CYP2J2 Deficiency in the Pathogenesis of Crohn's Disease?	causal interaction,ongoing research,therapeutic application,unassigned	4,4,3,0	
1.14.14.73	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25796175&form=6&db=m	CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population.	unassigned	-	
1.14.14.73	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27396818&form=6&db=m	Gene- gene interaction between CYP2J2 and PPAR -? gene on late-onset Alzheimer's disease in the eastern Chinese Han population.	diagnostic usage,ongoing research,therapeutic application,unassigned	1,2,1,0	
1.14.14.73	Aortic Aneurysm, Abdominal	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23446230&form=6&db=m	CYP2J2 Overexpression Increases EETs and Protects against Angiotensin II-Induced Abdominal Aortic Aneurysm in Mice.	therapeutic application,unassigned	1,0	
1.14.14.73	Arrhythmias, Cardiac	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24023684&form=6&db=m	CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy.	causal interaction,therapeutic application,unassigned	1,2,0	
1.14.14.73	Asthma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17475630&form=6&db=m	Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,4,4,2	
1.14.14.73	Atherosclerosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17429317&form=6&db=m	CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,2,1	
1.14.14.73	Atherosclerosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26859195&form=6&db=m	CYP2J2 Overexpression Increases EETs and Protects Against HFD-induced Atherosclerosis in ApoE-/- Mice.	causal interaction,ongoing research,therapeutic application,unassigned	2,3,1,0	
1.14.14.73	Atherosclerosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28000856&form=6&db=m	CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation.	ongoing research,unassigned	4,0	
1.14.14.73	Brain Infarction	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23041291&form=6&db=m	Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.	causal interaction,ongoing research,therapeutic application,unassigned	3,2,4,0